Chemotherapy induced oxidative stress in the ovary: drug-dependent mechanisms and potential interventions
暂无分享,去创建一个
[1] S. Sciarretta,et al. Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay , 2022, Cells.
[2] R. S. Barberino,et al. Protective Effects of Antioxidants on Cyclophosphamide-Induced Ovarian Toxicity. , 2022, Biopreservation and biobanking.
[3] N. Suzuki,et al. Paclitaxel is evidence to reduce growing ovarian follicle growth in mice model study. , 2022, Toxicology in vitro : an international journal published in association with BIBRA.
[4] H. O’Neill,et al. Genetic associations with polycystic ovary syndrome: the role of the mitochondrial genome; a systematic review and meta-analysis , 2022, Journal of Clinical Pathology.
[5] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[6] D. Woods,et al. Role of Granulosa Cells in the Aging Ovarian Landscape: A Focus on Mitochondrial and Metabolic Function , 2022, Frontiers in Physiology.
[7] S-F Zheng,et al. Effects of quercetin on ovarian function and regulation of the ovarian PI3K/Akt/FoxO3a signalling pathway and oxidative stress in a rat model of cyclophosphamide‐induced premature ovarian failure , 2021, Basic & clinical pharmacology & toxicology.
[8] Fenge Li,et al. Oxidative stress in oocyte aging and female reproduction , 2021, Journal of cellular physiology.
[9] Songying Zhang,et al. Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and Maternal Factors’ Transcription During Oocyte Growth , 2021, Frontiers in Cell and Developmental Biology.
[10] Karla J. Hutt,et al. Evaluation of mitochondria in mouse oocytes following cisplatin exposure , 2021, Journal of Ovarian Research.
[11] V. Apostolopoulos,et al. Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations , 2021, Cancers.
[12] Bo Yang,et al. Natural products: potential treatments for cisplatin-induced nephrotoxicity , 2021, Acta Pharmacologica Sinica.
[13] Jiaqiang Xiong,et al. Therapy of Endocrine Disease: Novel protection and treatment strategies for chemotherapy-associated ovarian damage. , 2021, European journal of endocrinology.
[14] Y. Kuang,et al. Quercetin prevents primordial follicle loss via suppression of PI3K/Akt/Foxo3a pathway activation in cyclophosphamide-treated mice , 2020, Reproductive Biology and Endocrinology.
[15] Carmen L. Wilson,et al. Cohort Profile: The St. Jude Lifetime Cohort Study (SJLIFE) for paediatric cancer survivors. , 2020, International journal of epidemiology.
[16] O. Bahri,et al. Evaluation of ovarian reserve before and after chemotherapy. , 2020, Journal of gynecology obstetrics and human reproduction.
[17] H. Abrahamse,et al. Redox Potential of Antioxidants in Cancer Progression and Prevention , 2020, Antioxidants.
[18] Jenifer R Prosperi,et al. Mechanisms of Taxane Resistance , 2020, Cancers.
[19] J. Abe,et al. Mitochondria and chronic effects of cancer therapeutics: The clinical implications , 2020, Journal of Thrombosis and Thrombolysis.
[20] N. Webster,et al. Mitochondrial-dysfunction in obesity and reproduction. , 2020, Endocrinology.
[21] J. Bhardwaj,et al. Ameliorating Effects of Natural Antioxidant Compounds on Female Infertility: a Review , 2020, Reproductive Sciences.
[22] G. Bedoschi,et al. Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer , 2020, Breast Cancer Research and Treatment.
[23] Yi Luan,et al. Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[24] Kezhen Li,et al. Transient impact of paclitaxel on mouse fertility and protective effect of gonadotropin-releasing hormone agonist , 2020, Oncology reports.
[25] K. Oktay,et al. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging. , 2020, Molecular human reproduction.
[26] Qian Deng,et al. Therapeutic Potential of Quercetin as an Antiatherosclerotic Agent in Atherosclerotic Cardiovascular Disease: A Review , 2020, Evidence-based complementary and alternative medicine : eCAM.
[27] U. Markert,et al. Doxorubicin induces cytotoxicity and miR-132 expression in granulosa cells. , 2020, Reproductive toxicology.
[28] P. Oliveira,et al. Mitochondrial Determinants of Doxorubicin-Induced Cardiomyopathy. , 2020, Circulation research.
[29] Gheyath K Nasrallah,et al. Potential Adverse Effects of Resveratrol: A Literature Review , 2020, International journal of molecular sciences.
[30] Weihua Huang,et al. Electrochemical Monitoring of Paclitaxel-Induced ROS Release from Mitochondria inside Single Cells. , 2019, Small.
[31] M. De Felici,et al. Ovarian damage from chemotherapy and current approaches to its protection , 2019, Human reproduction update.
[32] Lianwen Zheng,et al. Polycystic ovary syndrome and mitochondrial dysfunction , 2019, Reproductive Biology and Endocrinology.
[33] S. Ait-Oudhia,et al. Insights into Doxorubicin-induced Cardiotoxicity: Molecular Mechanisms, Preventive Strategies, and Early Monitoring , 2019, Molecular Pharmacology.
[34] Khoa N. Nguyen,et al. Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury , 2019, International journal of molecular sciences.
[35] J. Ferlay,et al. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. , 2019, The Lancet. Oncology.
[36] Shuai Jiang,et al. Mitochondrial electron transport chain, ROS generation and uncoupling (Review) , 2019, International journal of molecular medicine.
[37] Yuan-Lu Cui,et al. Antioxidant activities of quercetin and its complexes 2 for medicinal application 3 , 2019 .
[38] Meng Wu,et al. Resveratrol alleviates chemotherapy-induced oogonial stem cell apoptosis and ovarian aging in mice , 2019, Aging.
[39] T. Woodruff,et al. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide. , 2019, The Journal of endocrinology.
[40] Sumit Sharma,et al. Molecular mechanism involved in cyclophosphamide‐induced cardiotoxicity: Old drug with a new vision , 2019, Life sciences.
[41] H. Sampath,et al. Mitochondrial DNA Integrity: Role in Health and Disease , 2019, Cells.
[42] K. Qin,et al. Doxorubicin Induces ER Calcium Release via Src in Rat Ovarian Follicles , 2018, Toxicological sciences : an official journal of the Society of Toxicology.
[43] T. L. Kek,et al. Metabolomic profiling of serum in aging mice supplemented with tocotrienol-rich fraction for identification of female reproductive aging biomarkers , 2018, Malaysian Journal of Fundamental and Applied Sciences.
[44] M. Al-Omran,et al. Role of Endothelium in Doxorubicin-Induced Cardiomyopathy , 2018, JACC. Basic to translational science.
[45] A. Hacışevki,et al. An Overview of Melatonin as an Antioxidant Molecule: A Biochemical Approach , 2018, Melatonin - Molecular Biology, Clinical and Pharmaceutical Approaches.
[46] R. Goldenberg,et al. Doxorubicin-Induced Cardiotoxicity: From Mechanisms to Development of Efficient Therapy , 2018, Cardiotoxicity.
[47] K. Książek,et al. Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells , 2018, Cellular and Molecular Life Sciences.
[48] H. Kohan-Ghadr,et al. Acrolein, a commonly found environmental toxin, causes oocyte mitochondrial dysfunction and negatively affects embryo development , 2018, Free radical research.
[49] A. Mishra,et al. Resveratrol: A Double-Edged Sword in Health Benefits , 2018, Biomedicines.
[50] Yaoxing Chen,et al. A novel and compact review on the role of oxidative stress in female reproduction , 2018, Reproductive Biology and Endocrinology.
[51] Nikos Koundouros,et al. Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer , 2018, Front. Oncol..
[52] M. Bhori,et al. Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity – Exploring the armoury of obscurity , 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[53] Bhupinder Singh,et al. Administration of antioxidants in cancer: debate of the decade. , 2018, Drug discovery today.
[54] H. Kohan-Ghadr,et al. Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality , 2017, Free radical biology & medicine.
[55] M. Çaydere,et al. Dose dependent effect of resveratrol in preventing cisplatin-induced ovarian damage in rats: An experimental study. , 2017, Reproductive biology.
[56] M. Brand,et al. Production of superoxide and hydrogen peroxide from specific mitochondrial sites under different bioenergetic conditions , 2017, The Journal of Biological Chemistry.
[57] T. Najafi. Chemotherapy-Induced Oxidative Stress and Infertility , 2017 .
[58] Xinyang Zhang,et al. Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species. , 2017, Nano letters.
[59] Carmen L. Wilson,et al. Approach for Classification and Severity Grading of Long-term and Late-Onset Health Events among Childhood Cancer Survivors in the St. Jude Lifetime Cohort , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[60] M. Brand. Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling. , 2016, Free radical biology & medicine.
[61] Wang-ming Xu,et al. Oxidative Stress: Placenta Function and Dysfunction , 2016, American journal of reproductive immunology.
[62] R. Reiter,et al. Melatonin as an antioxidant: under promises but over delivers , 2016, Journal of pineal research.
[63] Subramani Parasuraman,et al. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid , 2016, Pharmacognosy reviews.
[64] M. Christianson,et al. Fertility Preservation: A Key Survivorship Issue for Young Women with Cancer , 2016, Front. Oncol..
[65] A. Qureshi,et al. Evaluation of Pharmacokinetics, and Bioavailability of Higher Doses of Tocotrienols in Healthy Fed Humans , 2016, Journal of clinical & experimental cardiology.
[66] J. Rosenberg,et al. Pharmacokinetics of oral and intravenous melatonin in healthy volunteers , 2016, BMC Pharmacology and Toxicology.
[67] Changwei Wang,et al. Taxane anticancer agents: a patent perspective , 2016, Expert opinion on therapeutic patents.
[68] S. Temin,et al. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. , 2016, Journal of oncology practice / American Society of Clinical Oncology.
[69] F. Ciani,et al. Influence of ROS on Ovarian Functions , 2015 .
[70] Ferda Özkan,et al. Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague-Dawley rats. , 2015, Reproductive biomedicine online.
[71] O. Krizanova,et al. Calcium and ROS: A mutual interplay , 2015, Redox biology.
[72] G. Froemming,et al. Tocotrienol preserves ovarian function in cyclophosphamide therapy , 2015, Human & experimental toxicology.
[73] C. Moraes,et al. Mechanisms linking mtDNA damage and aging. , 2013, Free radical biology & medicine.
[74] Abbas Ali Mahdi,et al. PI3K/PTEN/Akt and TSC/mTOR signaling pathways, ovarian dysfunction, and infertility: an update. , 2014, Journal of molecular endocrinology.
[75] M. Czaja,et al. Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling , 2014, Redox biology.
[76] Richard A. Anderson,et al. Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles , 2014, Molecular human reproduction.
[77] S. Horwitz,et al. Nature as a remarkable chemist: a personal story of the discovery and development of Taxol , 2014, Anti-cancer drugs.
[78] E. Niki. Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. , 2014, Free radical biology & medicine.
[79] A. Pandey,et al. Chemistry and Biological Activities of Flavonoids: An Overview , 2013, TheScientificWorldJournal.
[80] K. Brown,et al. Resveratrol in the management of human cancer: how strong is the clinical evidence? , 2013, Annals of the New York Academy of Sciences.
[81] K. Oktay,et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[82] Dong Li,et al. Differentially expressed genes in cisplatin-induced premature ovarian failure in rats. , 2013, Animal reproduction science.
[83] T. Tulandi,et al. Fertility Preservation Options After Gonadotoxic Chemotherapy , 2013, Clinical medicine insights. Reproductive health.
[84] Julie Brown,et al. Antioxidants for female subfertility. , 2013, The Cochrane database of systematic reviews.
[85] Shaista Malik,et al. The Sirtuin System: The Holy Grail of Resveratrol? , 2012, Journal of clinical & experimental cardiology.
[86] J. López-Novoa,et al. Subcellular targets of cisplatin cytotoxicity: an integrated view. , 2012, Pharmacology & therapeutics.
[87] Sajal Gupta,et al. The effects of oxidative stress on female reproduction: a review , 2012, Reproductive Biology and Endocrinology.
[88] Zeev Blumenfeld,et al. Chemotherapy and fertility. , 2012, Best practice & research. Clinical obstetrics & gynaecology.
[89] P. Ray,et al. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. , 2012, Cellular signalling.
[90] E. Chiocca,et al. Oral tocotrienols are transported to human tissues and delay the progression of the model for end-stage liver disease score in patients. , 2012, The Journal of nutrition.
[91] E. Perez,et al. Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[92] R. Norman,et al. The impact of obesity on oocytes: evidence for lipotoxicity mechanisms. , 2011, Reproduction, fertility, and development.
[93] I. Ben-Aharon,et al. Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes. , 2010, Reproductive toxicology.
[94] Ananda Sen,et al. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. , 2010, Cancer research.
[95] G. Bepler,et al. Physician referral for fertility preservation in oncology patients: a national study of practice behaviors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[96] N. Suzuki,et al. Ovarian toxicity of paclitaxel and effect on fertility in the rat , 2009, The journal of obstetrics and gynaecology research.
[97] Michael P. Murphy,et al. How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.
[98] U. Luderer,et al. Cyclophosphamide-induced apoptosis in COV434 human granulosa cells involves oxidative stress and glutathione depletion. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[99] T. A. Santos,et al. Mitochondrial content reflects oocyte variability and fertilization outcome. , 2006, Fertility and sterility.
[100] Sajal Gupta,et al. Role of oxidative stress in female reproduction , 2005, Reproductive biology and endocrinology : RB&E.
[101] M. Samiec. The role of mitochondrial genome [mtDNA] in somatic and embryo cloning of mammals. A review , 2005 .
[102] K. Conklin. Chemotherapy-Associated Oxidative Stress: Impact on Chemotherapeutic Effectiveness , 2004, Integrative cancer therapies.
[103] P Barrière,et al. Mitochondrial DNA content affects the fertilizability of human oocytes. , 2001, Molecular human reproduction.
[104] K. Davies,et al. Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. , 1989, The Biochemical journal.
[105] J. Doroshow,et al. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. , 1986, The Journal of biological chemistry.